Article summary
In August 2025, the psychedelics movement crossed an unprecedented threshold. The U.S. Drug Enforcement Administration (DEA) announced that it would forward a petition to reschedule psilocybin, the psychoactive compound found in “magic mushrooms”, to the Department of Health and Human Services (HHS) for scientific review. The post Psylutions and the DEA appeared first on Microdose.
Continue to the original publication for the complete article.